PAHC
Phibro Animal Health Corporation
37.20$
-0.1%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 63.6% | 56.2% | 58.3% | 61.9% | 64.2% | 57.6% | 59.3% | 60.8% | 60.3% | 61.2% | 59.6% | 62.3% | |
| 5.9% | 5.5% | 9.0% | 4.3% | 7.9% | 4.6% | 6.0% | 8.0% | 4.2% | 7.2% | 5.0% | 4.1% | |
| 5.9% | 5.5% | 9.0% | 11.8% | 11.2% | 11.6% | 11.1% | 9.8% | 8.4% | 11.7% | 5.7% | 5.5% | |
| 22.5% | 20.3% | 20.2% | 20.2% | 21.9% | 16.1% | 17.5% | 17.9% | 16.8% | 17.3% | 16.8% | 15.9% | |
| 30.4% | 27.5% | 25.9% | 26.5% | 27.3% | 25.1% | 25.7% | 27.8% | 28.6% | 27.1% | 32.7% | 35.6% | |
| 21.2% | 20.9% | 20.4% | 19.4% | 19.3% | 21.8% | 22.3% | 17.8% | 20.1% | – | – | – | |
| 2.6% | 3.5% | 3.8% | 4.1% | 3.8% | 6.7% | 6.3% | 5.7% | 5.5% | 5.6% | 4.4% | 4.0% | |
| 7.6% | 9.8% | 8.8% | 7.7% | 6.5% | 9.1% | 7.4% | 6.9% | 5.7% | 4.6% | 2.7% | 2.0% | |
| 94.0% | 85.2% | 75.8% | 72.5% | 70.3% | 76.0% | 71.6% | 71.8% | 70.9% | 73.9% | 79.0% | 74.3% | |
| 22.6% | 17.8% | 18.6% | 21.3% | 21.2% | 20.1% | 19.5% | 20.5% | 18.1% | 20.8% | 21.6% | 21.1% | |
| 0.6% | 0.5% | 1.0% | 1.9% | 1.7% | 3.2% | 1.9% | 2.3% | 2.9% | 3.8% | 1.9% | 2.4% | |
| 12.8% | 9.9% | 9.1% | 8.9% | 10.1% | 8.4% | 8.1% | 10.3% | 7.6% | 8.7% | 10.2% | 8.5% | |
| 0.6% | 11.3% | 10.4% | 10.4% | 13.2% | 47.0% | 45.5% | 44.9% | 46.6% | 46.7% | 51.6% | 47.1% | |
| 6.0% | 14.8% | 24.2% | 27.5% | 29.7% | 24.0% | 28.4% | 28.2% | 29.1% | 26.1% | 21.0% | 25.7% | |
| -7.5% | 5.6% | 13.3% | 19.6% | 23.2% | 23.3% | 25.9% | 26.6% | 26.9% | 24.8% | 20.0% | 23.5% | |
| 8.1% | 6.6% | 6.4% | 6.0% | 5.6% | 5.2% | 4.8% | 4.3% | 4.2% | 4.1% | 3.0% | 2.7% |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.